123 related articles for article (PubMed ID: 9337678)
1. Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy.
Fosså SD; Oliver RT; Stenning SP; Horwich A; Wilkinson P; Read G; Mead GM; Roberts JT; Rustin G; Cullen MH; Kaye SB; Harland SJ; Cook P
Eur J Cancer; 1997 Aug; 33(9):1380-7. PubMed ID: 9337678
[TBL] [Abstract][Full Text] [Related]
2. Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients.
Gholam D; Fizazi K; Terrier-Lacombe MJ; Jan P; Culine S; Theodore C
Cancer; 2003 Aug; 98(4):745-52. PubMed ID: 12910518
[TBL] [Abstract][Full Text] [Related]
3. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients.
Mencel PJ; Motzer RJ; Mazumdar M; Vlamis V; Bajorin DF; Bosl GJ
J Clin Oncol; 1994 Jan; 12(1):120-6. PubMed ID: 7505805
[TBL] [Abstract][Full Text] [Related]
4. [Management of advanced seminoma: retrospective study of 96 patients].
Bompas E; Fléchon A; Biron P; Droz JP
Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
[TBL] [Abstract][Full Text] [Related]
5. A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.
Fizazi K; Delva R; Caty A; Chevreau C; Kerbrat P; Rolland F; Priou F; Geoffrois L; Rixe O; Beuzeboc P; Malhaire JP; Culine S; Aubelle MS; Laplanche A
Eur Urol; 2014 Feb; 65(2):381-6. PubMed ID: 24094847
[TBL] [Abstract][Full Text] [Related]
6. Serum lactate dehydrogenase and human choriogonadotrophin in seminoma.
Fosså A; Fosså SD
Br J Urol; 1989 Apr; 63(4):408-15. PubMed ID: 2653557
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party.
Duchesne GM; Stenning SP; Aass N; Mead GM; Fosså SD; Oliver RT; Horwich A; Read G; Roberts IT; Rustin G; Cullen MH; Kaye SB; Harland SJ; Cook PA
Eur J Cancer; 1997 May; 33(6):829-35. PubMed ID: 9291801
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of LDH levels in patients with relapsed/refractory seminoma.
Powles T; Bascoul-Mollevi C; Kramar A; Lorch A; Beyer J
J Cancer Res Clin Oncol; 2013 Aug; 139(8):1311-6. PubMed ID: 23640062
[TBL] [Abstract][Full Text] [Related]
9. Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
Beyer J; Collette L; Sauvé N; Daugaard G; Feldman DR; Tandstad T; Tryakin A; Stahl O; Gonzalez-Billalabeitia E; De Giorgi U; Culine S; de Wit R; Hansen AR; Bebek M; Terbuch A; Albany C; Hentrich M; Gietema JA; Negaard H; Huddart RA; Lorch A; Cafferty FH; Heng DYC; Sweeney CJ; Winquist E; Chovanec M; Fankhauser C; Stark D; Grimison P; Necchi A; Tran B; Heidenreich A; Shamash J; Sternberg CN; Vaughn DJ; Duran I; Bokemeyer C; Patrikidou A; Cathomas R; Assele S; Gillessen S;
J Clin Oncol; 2021 May; 39(14):1553-1562. PubMed ID: 33729863
[TBL] [Abstract][Full Text] [Related]
10. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.
Fosså SD; Droz JP; Stoter G; Kaye SB; Vermeylen K; Sylvester R
Br J Cancer; 1995 Mar; 71(3):619-24. PubMed ID: 7880748
[TBL] [Abstract][Full Text] [Related]
12. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy intensification in patients with advanced seminoma and adverse prognostic factors.
Fedyanin M; Tryakin A; Bulanov A; Vybarava A; Tjulandina A; Chekini D; Sekhina O; Figurin K; Garin A; Tjulandin S
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1259-64. PubMed ID: 25586890
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3).
Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser CD; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Raggi D; Aurilio G; Casadei C; Hentrich M; Tran B; Dieckmann KP; Brito M; Ruf C; Mazzocca A; Vincenzi B; Stahl O; Bokemeyer C; Oing C
World J Urol; 2021 Sep; 39(9):3407-3414. PubMed ID: 33683412
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-based chemotherapy in advanced seminoma: experience of the Northern Israel Oncology Center: 1981-1994.
Stein ME; Kuten A; Drumea K; Moshkowitz B; Nativ C; Munichor M; Haim N
J Surg Oncol; 1997 Apr; 64(4):331-5. PubMed ID: 9142192
[TBL] [Abstract][Full Text] [Related]
16. Management of stage II seminoma.
Warde P; Gospodarowicz M; Panzarella T; Catton C; Sturgeon J; Moore M; Jewett M
J Clin Oncol; 1998 Jan; 16(1):290-4. PubMed ID: 9440755
[TBL] [Abstract][Full Text] [Related]
17. E400P in advanced seminoma of good prognosis according to the international germ cell cancer collaborative group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experience.
Arranz Arija JA; García del Muro X; Gumà J; Aparicio J; Salazar R; Saenz A; Carles J; Sánchez M; Germà-Lluch JR
Ann Oncol; 2001 Apr; 12(4):487-91. PubMed ID: 11398880
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy for metastatic germ cell tumours of the testis].
Culine S
Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740
[TBL] [Abstract][Full Text] [Related]
19. [Difficulty in evaluation of the effectiveness of BEP chemotherapy in a patient with testicular seminoma].
Ohsugi H; Kinoshita H; Kawa G; Matsuda T
Hinyokika Kiyo; 2013 Jun; 59(6):389-93. PubMed ID: 23827875
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-based chemotherapy in advanced seminoma: the Institut Gustave Roussy experience.
Culine S; Abs L; Terrier-Lacombe MJ; Théodore C; Wibault P; Droz JP
Eur J Cancer; 1998 Feb; 34(3):353-8. PubMed ID: 9640221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
